Expression of metallothionein and glutathione in ovarian carcinomas;Die expression von metallothionein und glutathion im tumorgewebe von ovarialkarzinomen

Geburtshilfe und Frauenheilkunde

Volumn 62, Issue 2, 2002, Pages 145-154

  Tanner, Berno ^a   Pilch, H ^a   Schmidt, M ^a   Hengstler, J G ^b  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Glutathion; Histological grade; Metallothionein; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CYSTEINE; GLUTATHIONE; ISOPROTEIN; METALLOTHIONEIN; PLATINUM; THIOL DERIVATIVE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER RESISTANCE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PROTEIN CONTENT; PROTEIN EXPRESSION; SURVIVAL TIME; TUMOR CELL;

EID: 0036217554     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-22112     Document Type: Article

References (33)

1. Immunohistochemical localization of metallothionein in transitional cell carcinoma of bladder
2. Suppression of dexamethasone-induced metallothionein expression and cis-diamminedichlorplatinum(II)resistance by vmos
3. 2nd-line-chemotherapie nach platin- oder platin-paclitaxel-haltiger primärtherapie beim ovarialkarzinom: Eine systematische Übersicht der publizierten daten
4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
5. Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast. No correlation
6. Markers of chemoresistance in ovarian carcinomas: An immunohistochemical study of 86 cases
7. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine
8. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer
9. Activity of O(6)-methylguanine-DNA methyltransferase on relation to p53 status and therapeutic response in ovarian cancer
10. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin
11. Overexpression of metallothionein confers resistance to anticaner drugs
12. Enhanced apoptosis in metallothionein null cells
13. Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity
14. Differentiell effects on cell killing in metallothionein overexpressing CHO mutant cell lines
15. A cadmium protein from equine kidney cortex
16. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium
17. Overexpression of the oncogene c-erbB-2 (HER2/neu) and response to chemotherapy in patients with ovarian cancer
18. Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse
19. Metallothionein in physiological and physiopathological processes
20. Metallothionein levels in ovarian tumours before and after chemotherapy
21. Preferential binding of copper to the beta domain of metaliothionein
22. Increased sensitivity of a Chinese hamster ovary cell line to alkylating agents after overexpression of the human metallothionein II-A gene
23. Immunhistochemischer nachweis des glukose-transportproteins GLUT-1 in primären ovarialkarzinomen - Ein charakteristikum des malignen phänotyps
24. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer
25. Invasions- und proliferationsfaktoren bei LMP-tumoren des ovars: Mögliche konsequenzen für die klinik
26. Glutathione, glutathione S-transferase alpha and pi, and aldehyde dehydrogenase content in relationship to drug resistence in ovarian cancer
27. mdm2 mRNA expression is associated with survival in ovarian cancer
28. Cmyc mRNA expression in epithelial ovarian carcinomas in relation to estrogen receptor status, metastatic spread, survival time, FIGO stage, and histologic grade and type
29. Prognostic significance of c-erbB-2 mRNA in ovarian cancer
30. Metallothionein gene expression in bladder cancer exposed to cisplatin
31. Effects of oncogenes on the resistance to cis-diamminedichloro-platinum (11) and metallothionein gene expression